Kunal Mahajan
Kunal Mahajan is an expert in Cardiology at Indira Gandhi Medical College (India). As of October 2026, ScienceLeadR ranks Kunal Mahajan in the top 1% of experts in India for Myocardial Ischemia. Kunal Mahajan has authored 183 publications, the most recent in 2026. SLR score: 620 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Endocrinology - Pharmacy - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 183
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy. PMID 42949291 — mortality, hemorrhage, stroke, myocardial infarction, proton pump inhibitors, pharmacology, omeprazole, therapeutics, blood platelets, proton pumps | Aliment Pharmacol Ther | 2026 | 0 |
| Trimetazidine in Heart Failure: From Metabolic Modulation to Clinical Outcomes-A Narrative Review. PMID 42943360 — trimetazidine, mortality, ventricular remodeling, heart failure, heart, oxidative stress, heart failure, systolic, therapeutics | Pharmaceuticals (Basel) | 2026 | 0 |
| Periconceptional and early-pregnancy exposure to SGLT2 inhibitors and congenital malformations: a systematic review and meta-analysis. PMID 42891874 — diabetes mellitus, sodium-glucose transporter 2 inhibitors, congenital abnormalities, pregnancy, hormones, diabetes mellitus, type 2 | Endocrine | 2026 | 0 |
| LDL-Cholesterol Targets Post-ACS and CCS: Why Early Goal Achievement Counts. PMID 42886107 — achievement, cholesterol, ldl, acute coronary syndrome, secondary prevention, cholesterol | JACC Asia | 2026 | 0 |
| Beyond muscle: could GLP-1 receptor agonists offset the tendon risk of intensive lipid-lowering therapy? PMID 42877717 — glucagon-like peptide 1, glucagon-like peptide-1 receptor, muscles, tendons, therapeutics | Arch Med Sci | 2026 | 0 |
LeadR Networks
Main global connection map